Clinical Trials
134 trialsBV-MAZOVIA
Takeda
VIRONMENT
Assistance Publique - Hôpitaux de Paris
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
National Institutes of Health Clinical Center (CC)
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Memorial Sloan Kettering Cancer Center
Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma
The First Affiliated Hospital of Soochow University
Collection of Tissue Samples for Cancer Research
National Institutes of Health Clinical Center (CC)
LEO
Mayo Clinic
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
National Institutes of Health Clinical Center (CC)
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
National Institutes of Health Clinical Center (CC)
Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins
National Institutes of Health Clinical Center (CC)
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
National Institutes of Health Clinical Center (CC)
Clonal Evolution in Follicular Lymphoma
National Institutes of Health Clinical Center (CC)
Sample Collection and Tracking for the Developmental Therapeutics Clinic
National Institutes of Health Clinical Center (CC)
Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
National Institutes of Health Clinical Center (CC)
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
National Institutes of Health Clinical Center (CC)
FERTILymph
University Hospital, Lille
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
National Institutes of Health Clinical Center (CC)
Pilot Prospective Study for PET-CT Imaging in Participants With Relapsed/Refractory Acute Leukemias
National Institutes of Health Clinical Center (CC)
Real World Asparaginase Therapy Toxicity
St. Jude Children's Research Hospital
REALITY-RO
Janssen Research & Development, LLC
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
National Institutes of Health Clinical Center (CC)
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
M.D. Anderson Cancer Center
A Registry for People With T-cell Lymphoma
Memorial Sloan Kettering Cancer Center
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
St. Jude Children's Research Hospital
REVEAL
Ono Pharmaceutical Co., Ltd.
Biomarker for Infection Risk in CLL and MM
Massachusetts General Hospital
AQUALIS
AstraZeneca
0150-24 SOR
Soroka University Medical Center
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Children's Oncology Group
RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Pfizer
Pediatric Vaccinations
NYU Langone Health
CLL registry
AstraZeneca
Study Protocol: Study on Incidence and Risk Factors of Mold Infections in Children During Leukemia Treatment
University of Southern Denmark
An Endotracheal Tube Inserted to the Level of the Hypopharynx
American University of Beirut Medical Center
Autologous Versus Allogeneic Hematopoietic Stem Cell Transplantation for T-Lymphoblastic Leukemia/Lymphoma in First Complete Remission
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
Economic Analysis of Alliance A041202 CLL Study
Canadian Cancer Trials Group
OPAL
Janssen Biotech, Inc.
SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes
Rigshospitalet, Denmark
QOLIBRI
Janssen Cilag S.A.S.
LeukemiaCort
University Children's Hospital Basel
Genetic Studies of Chronic Active Epstein-Barr Disease
National Institutes of Health Clinical Center (CC)
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Dana-Farber Cancer Institute
Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:
Canadian Cancer Trials Group
SEIFEM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Eastern Cooperative Oncology Group
Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Dana-Farber Cancer Institute
Tissue Collection for Studies of Lymph Cancer
National Institutes of Health Clinical Center (CC)
Project: Every Child for Younger Patients With Cancer
Children's Oncology Group
Long-term Follow up Local Registry Study of Kymriah in South Korea
Novartis